These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19508621)

  • 81. Is interleukin-10 antifibrogenic in chronic liver injury?
    Tsukamoto H
    Hepatology; 1998 Dec; 28(6):1707-9. PubMed ID: 9828239
    [No Abstract]   [Full Text] [Related]  

  • 82. Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
    Eissa AA; Farag NA; Soliman GA
    Bioorg Med Chem; 2009 Jul; 17(14):5059-70. PubMed ID: 19527932
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of 5-trifluoromethyl-4,5-dihydro-1H-pyrazoles on chronic inflammatory pain model in rats.
    Sauzem PD; Sant'Anna Gda S; Machado P; Duarte MM; Ferreira J; Mello CF; Beck P; Bonacorso HG; Zanatta N; Martins MA; Rubin MA
    Eur J Pharmacol; 2009 Aug; 616(1-3):91-100. PubMed ID: 19540223
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Animal models of liver fibrosis.
    Wu J; Norton PA
    Scand J Gastroenterol; 1996 Dec; 31(12):1137-43. PubMed ID: 8976003
    [No Abstract]   [Full Text] [Related]  

  • 85. Fibrophilia: a new disease entity?
    Levi M; Dik K
    J Thromb Haemost; 2008 Aug; 6(8):1334-5. PubMed ID: 18564217
    [No Abstract]   [Full Text] [Related]  

  • 86. Growing muscle against cirrhosis: In the quest for models to revealing mechanisms.
    Asensio I; Vaquero J
    Liver Int; 2019 Apr; 39(4):625-627. PubMed ID: 30916864
    [No Abstract]   [Full Text] [Related]  

  • 87. Dietary fat and cirrhosis in the rat.
    Nutr Rev; 1966 Jun; 24(6):189-91. PubMed ID: 5327433
    [No Abstract]   [Full Text] [Related]  

  • 88. Major hepatectomy for the treatment of complex bile duct injury.
    Mercado MA; Sanchez N; Urencio M
    Ann Surg; 2009 Mar; 249(3):542-3; author reply 543. PubMed ID: 19247049
    [No Abstract]   [Full Text] [Related]  

  • 89. Rapeseed in prevention of experimental cirrhosis.
    Alvizouri M; Esquivel F; Molina A
    Lancet; 1978 Oct; 2(8096):951-2. PubMed ID: 81975
    [No Abstract]   [Full Text] [Related]  

  • 90. [Systematization of the nerve pedicles of the liver; effect of their experimental resection on the tonus of the bile ducts].
    MALLET-GUY P; EICHOLZ L; DESCOTES J; POPOVIC I
    Lyon Chir; 1955; 50(4):445-54. PubMed ID: 14393027
    [No Abstract]   [Full Text] [Related]  

  • 91. Antifatty liver action of proteolytic enzymes of animal and plant origin in pancreatic duct-ligated rats.
    SACHDEV JC
    Gastroenterology; 1954 Sep; 27(3):353-7. PubMed ID: 13200721
    [No Abstract]   [Full Text] [Related]  

  • 92. Dangerous liaisons: drug, host and the environment.
    Aithal GP
    J Hepatol; 2007 Jun; 46(6):995-8. PubMed ID: 17445937
    [No Abstract]   [Full Text] [Related]  

  • 93. [Bile secretion by rat liver. III. Effect of acetazolamide].
    BIZARD G; VANLERENBERGHE J; ROBELET A; MILBLED G; GUERRIN F
    Therapie; 1958; 13(6):1006-25. PubMed ID: 13625213
    [No Abstract]   [Full Text] [Related]  

  • 94. Further investigations on the cirrhogenic effect of a desiccated whole bile preparation.
    HOLSTI P
    Acta Pathol Microbiol Scand; 1960; 50():377-82. PubMed ID: 13715525
    [No Abstract]   [Full Text] [Related]  

  • 95. [Bile secretion by the rat liver. IV. Effect of meralluride].
    BIZARD G; VANLERENBERGHE J; GUERRIN F; ROBELET A; MILBLED G
    J Physiol (Paris); 1958 Mar; 50(2):157-9. PubMed ID: 13550101
    [No Abstract]   [Full Text] [Related]  

  • 96. Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver.
    Kapoor S; Bahde R
    Liver Int; 2009 Aug; 29(7):1125; author reply 1125-6. PubMed ID: 19508621
    [No Abstract]   [Full Text] [Related]  

  • 97. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
    Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
    Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Study on the mechanism of preventing alcholic liver disease by selective cyclooxygenase 2 inhibitor].
    Zhou JY; Zhou DF; Liu YH; Wang W; Wei F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):559-60. PubMed ID: 19912698
    [No Abstract]   [Full Text] [Related]  

  • 99. Effect of celecoxib on experimental liver fibrosis in rat.
    Hui AY; Leung WK; Chan HL; Chan FK; Go MY; Chan KK; Tang BD; Chu ES; Sung JJ
    Liver Int; 2006 Feb; 26(1):125-36. PubMed ID: 16420518
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Experimental models of hepatic fibrosis in the rat.
    Wasser S; Tan CE
    Ann Acad Med Singap; 1999 Jan; 28(1):109-11. PubMed ID: 10374036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.